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Summary Seventy-five nude mice received subcutaneous inoculation with 1 x 107 cells of the human colonic
cancer cell lines COLO-320 or HT-29. Tumour growth was assessed over 4 weeks in animals given one of
three iso-caloric diets: standard diet, high saturated fat (20% coconut) diet and high n-3 fat (20% Maxepa fish
oil) diet. The n-3 diet produced significant tumour growth reduction compared to the other diets for
COLO-320 at 3 to 4 weeks (P<0.05 at least) and similarly for HT-29 at 4 weeks (P<0.05). Significant
incorporation of n-3 fatty acids occurred in red cell membranes, adipose tissue and both neutral lipid and
phospholipid fractions of tumour lipids in animals fed Maxepa (P<0.01 at least). This was accompanied by
reduction of linoleic acid and arachidonic acid in these tissues (P<0.01 at least) but was most marked in the
metabolically labile phospholipid fraction. There was high mitotic activity in the tumours from all the groups
but there was no difference according to diet.
Colorectal cancer is now the second commonest cause of
cancer death in Westernised countries; epidemiological
studies strongly point to an association with a high dietary
fat intake, particularly of animal origin (Armstrong & Doll,
1975; Nicholson et al., 1988). The major component of
dietary fat is triacylyglcerols containing long-chain fatty
acids. That high levels (-20%) of exogenous saturated fatty
acids can promote colorectal cancer relative to low levels
(-5%) has been shown in a number of experimental studies
(Bull et al., 1979; Galloway et al., 1987; Nicholson et al.,
1990a; Nigro et al., 1975; Reddy et al., 1977).
The study of specific fats in the aetiology of colorectal
cancer in humans has not been adequately determined given
the crude nature of epidemiological dietary data and the
difficulty in applying reliable dietary assessment techniques to
large populations (Bingham, 1987). Whilst animal experi-
ments have confirmed the tumour promoting potential of
saturated fats, the role of unsaturated fatty acids is somewhat
controversial. Some authors have reported that dietary fats
of vegetable origin which are rich in linoleic acid (18:2, n-6)
have a potent co-carcinogenic effect in experimental colon
cancer not only at high dietary levels but also at low levels
(Broitman et al., 1977; Lochniskar et al., 1985; Reddy et al.,
1985; Sakaguchi et al., 1984; Smedley-Machlean & Nunn,
1941; Wilson & Lindsey, 1965); others have not (Dayton et
al., 1977; Nicholson et al., 1990b).
Nevertheless, that differences may exist between fatty acid
classes in terms of cancer promotion suggests specific struc-
tural requirements for such a process. Numerous mechanisms
have been proposed, including effects on bile acids (Reddy et
al., 1985), direct luminal effects (Friedman et al., 1989),
alterations in lipid peroxidation (Begin & Das, 1986), pertur-
bations in membrane fluidity (Brasitus et al., 1985), changes
in immune cytotoxicity (Schlager & Ohanian, 1980) and
modulation of prostaglandin synthesis (Wickremasinghe,
1988).
Although fatty acids can be synthesised from glucose in
cancer cells (Kanan et al., 1980), this is reduced in the
presence of an adequate exogenous supply (McGee & Spec-
tor, 1975). In cancer there is reduced re-esterification of free
fatty acids in both experimental models (Ooktens et al., 1986)
and in patients (Legaspi et al., 1987); this could result in
increased peripheral utilisation of dietary fatty acids not only
by the host tissues but by the cancer tissue. This therefore
implies that certain exogenous fatty acids could be used as
pharmacological agents and such a role has been proposed
for the n-3 series of fatty acids (Begin & Das, 1986). Thus,
three recent studies have shown reduced colon carcinogenesis
in azoxymethane treated rodents given dietary n-3 lipids
(Reddy & Maruyama, 1986; Reddy & Sugie, 1988; Minoura
et al., 1988).
In the present study we sought to examine the role of
dietary n-3 fatty acids on the growth of two human colon
cancer cell lines inoculated into nude mice; this was com-
bined with fatty acid analysis of host and tumour tissue lipids
in order to investigate underlying processes of metabolism.
Methods
Animals andexperimental design
Six to eight week old BALB/c nude mice were obtained from
the Department of Cancer Studies, University of Birming-
ham, UK, and were housed five per cage in an isolated room
at 22°C. During 1 to 2 weeks acclimatisation, the mice were
allowed free access to a (sterilised) standard mouse diet (Diet
10mm (422), Pilsbury's Ltd, Birmingham, UK) with water
ad libitum. Cohorts of animals were divided into six groups
of 12 to 13 mice per group according to the type of experi-
mental diet and tumour cell line inoculated subcutaneously
(s.c.). The animals were commenced on the experimental
diets the following day. Tumour measurements were under-
taken at weekly intervals for the 4 subsequent weeks. They
were examined daily and weighed weekly. On the fourth
week (i.e. 5 weeks after cell inoculation) the animals were
sacrificed and blood, subcutaneous adipose tissue and
tumour were removed for lipid analysis. The tumours were
weighed and divided into two for separate histological
examination as well as lipid analysis. Animals with tumours
which did not take following inoculation were excluded at 1
week. For humanitarian reasons, animals not sustaining
health because of tumour growth were killed before 4 weeks.
A further three groups of five mice each were used as cont-
rols (without tumours) to compare animal growth rates.
Preliminary studies in animals both with and without
tumour inoculations were found to consume a constant 8 g
of the experimental diets and standard diet for the duration
of the experiment. This was therefore used during the course
of the main experiment. The size of the tumour inoculation,
as well as the duration of the experiment based on tumour
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growth rates, were also determined in these preliminary
experiments.
Human colon cancer cell lines
These were obtained from the European collection of Animal
Cell Cultures (Salisbury, UK). They were propagated in
medium containing RPMI 1640 (90%), heat inactivated
foetal bovine serum 10%, penicillin and streptomycin at 37°C
in a humidified 5% CO, atmosphere.
COLO-320 HSR (ATCC CCL 220.1): is an adenocarcinoma
derived from the colon and is a substrain ofCOLO 320 DM; it
does not express carcinoembryonic antigen.
HT-29 (ATCC HTB 38): is a moderately well-differentiated
adenocarcinoma derived from colon which expresses car-
cinoembryonic antigen.
For each animal 1 x 10' cells in 0.2 ml phosphate buffered
saline (PBS) were injected into the dorsum of the chest wall
subcutaneously using a 27 g needle.
Experimental diets
The standard diet (diet 10 mm (422) Pilsbury's Ltd, Birming-
ham, UK) contained the following calculated amounts: fat
5.6%, protein 20.3%, fibre 37.6%, ash 8.99%, starch 36.11%
and sugar 3.04%, as well as electrolytes, trace elements and
vitamins; the amount of vitamin E (dl-alpha-tocopherol ace-
tate) was 0.07 mg g-'. A high (20%) saturated fat diet and a
high 20% n-3 fat diet was prepared by adding (W/W) coco-
nut oil (KTC Ediblestin, Wednesbury, Birmingham, UK) and
Maxepa oil (Duncan Flockhart Ltd, London, UK) to a low
fat cereal based diet (Special Diet Services, Witham, Essex,
UK). The base diet contained the following calculated
amounts: fat 0.8%, protein 15%, fibre 5.6%, ash 4.8%,
starch 54.4% and sugar 8.3% and also electrolytes, trace
elements and vitamins. Both the high fat diets contained
I mg g-' of vitamin E and 1 jg g'l of selenium. In addition,
the Maxepa diet contained small amounts of dodecyl gallate
and <0.01% (W/W) of cholesterol. The calculated energy
value for the standard diet was 11.8MJkg-' and 12.9MJ
kg-' for the high fat diets. Both the high fat diets were
prepared daily in order to avoid auto-oxidation of highly
unsaturated fatty acids. Determination of the fatty acids in
these diets was undertaken using chloroformmethanol extrac-
tion and analysis of the methyl esters using gas-liquid
chromatography (see below). The fatty acid composition of
these three diets is shown in Table I.
Assessment oftumour growth
Tumour volumes and weight were performed using minor
modifications of previously described techniques (Euhus et
al., 1986; Fiennes, 1988). The coefficient of correlation
between tumour weight and tumour volume measured by
these techniques in two separate experiments was r = 0.945
(n = 13) and r = 0.988 (n = 10), both P<0.001. Some diverg-
ence of the volumetric method from actual weights was noted
with very large tumours due to subdermal invasion despite
being situated over the rib cage.
Analyticalprocedures
At death 1.5 ml of blood was drawn into EDTA coated
tubes. Red cell membranes were prepared, lipids extracted,
saponified and fatty acids derivatised to the methyl esters
exactly as previously described (Neoptolemos & Thomas,
1990). In all analytical procedures, samples were kept on ice
and the antioxidant butylated-hydroxytoluene was used.
Adipose tissue and tumour tissue were weighed and then
snap frozen and stored in liquid nitrogen. Lipids were
extracted from these tissues using a technique previously
described (Bligh & Dyer, 1959). In the case of tumour lipids
these were separated into neutral lipid and phospholipid
fractions prior to saponification. Briefly, silica Sep-Pak cart-
ridges were primed with methanol and chloroform and
Table I Fatty acid composition of the three experimental diets,
determined as described in the methods
Experimental diets (%fatty acids)
High saturated High n-3fat
Fatty acid Standard diet fat (coconut oil) (Maxepa oil)
6:0 <0.1 0.66 <0.1
8:0 0.93 7.50 <0.1
10:0 1.05 7.97 <0.1
12:0 6.92 26.12 <0.1
14:0 3.89 22.74 7.31
16:0 16.73 11.54 16.62
16:1 (n-7) <0.1 <0.1 9.70
18:0 16.84 4.60 3.83
18:1 (n-9) 38.79 9.64 11.35
18:2 (n-6) 10.57 3.97 2.46
18:3 (n-3) <0.1 <0.1 0.84
20:0 <0.1 <0.1 3.24
20:1 <0.1 <0.1 1.83
20:4 (n-6) 2.10 <0.1 <0.1
20:5 (n-3) <0.1 <0.1 17.69
22:5 (n-3) <0.1 <0.1 0.60
22:6 (n-3) <0.1 <0.1 14.45
Unspecified 1.38 4.8 7.68
Total saturated 46.63 81.13 38.30
Total n-3 <0.1 <0.1 35.68
Total lipids 4.6 20 20
% Diet (w/w)
loaded with 0.5 ml of the crude total lipid. Addition of 20 ml
of chloroform resulted in separation of the neutral lipids
followed by the phospholipid fraction with 2 ml of methanol.
Complete separation was confirmed by thin layer chromato-
graphy (TLC) on silica plates using chloroform:methanol:
acetic acid:distilled water (170:15:15:12) and identification
with 50% sulphuric acid and charring. Subsequent treatments
of these lipids was as described for the red cell membranes.
With these methods the extraction of all the major fatty acids
from red cells, adipose tissue and tumour tissue was 95-
100% with coefficients of variation of <5%.
Fatty acid methyl esters (FAMES) were analysed by gas-
liquid chromatography (GLC) using a Phillips PU 4400
chromatograph (Cambridge, UK) with a programmable
temperature vapouriser (PTV), flame ionisation detector,
Phillips PU 6600 data station and computer integrator and
automatic injection. An open tube capillary column was used
(WCOT Fused Silica, 0.22 mm x 50 M, Chrompak Ltd, Hol-
land) either in the PTV or split mode and 1 fsl sample
injection. Ultra-pure gases were used and were further puri-
fied prior to entry into the chromatograph using the follow-
ing filters: Oxyfilter, Moisture Filter and Charcoal Filters x 2
(Chrompack UK, Ltd, Catalogue nos. 7470-7972). The sett-
ings were as follows: H2 2.8 bar, air 2.4 bar and helium
1.5 bar (flow rate of 1.6 ml min-'); the injection port temper-
ature was 260°C for the split mode; PTV mode settings were
8 x 10°C initially followed by 33 x 10°C at full ramp rate
(24°C s-') with solvent evaporation; the column temperature
was 150°C initially for 2 min ramping to 2°C min-' to 200°C
and then 5°C min ' to 240°C and held for 15 min; detection
temperature was set at 300°C.
Identification of peaks was made by reference to retention
times relative to an internal standard (margaric acid, 17:0) on
samples and previous analysis using authentic standards. At
least two separate runs were made per sample and their
values meaned. Quantification was based on integration of
clearly separated peaks.
Tumour protein content was determined using the Lowry
technique (Lowry et al., 1951).
Histology
This was undertaken on coded tissue specimens by one histo-
pathologist (M.N.). Mitotic counts were undertaken in 50
high power fields (HPF; x 400 magnification) for each of the
different groups.744 M. SAKAGUCHI et al.
Sources ofgases andmaterials
Helium CP grade (>999.999% pure), hydrogen-hydrocar-
bon zero grade (>99.999% pure) and air - BTCA74 (<1
v.p.m. hydrocarbons, <1 v.p.m. CO2 and <0.1 v.p.m. nitric
oxide) were supplied by BOC-Special Gases, UK. Silica Sep-
Pak (3 ml, 500 mg) were obtained from Waters Association
(Milford, MA, USA) and the TLC plates (ART 11845) from
Merk (Darmstadt, Germany). Chloroform, methanol and
acetic acid (all AR grade) were obtained from FSA (Bishop
Meadow Road, Loughborough, UK), and ethanol from
James Burrough (Witham, Essex, UK). All remaining re-
agents and solvents, including Lowry reagents, the internal
standard and FAME authentic standards were from Sigma
UK LTd (Poole, Dorset, UK).
Statistical analysis
Analysis of multiple groups was undertaken using the Krus-
kal-Wallis test; with significance thus obtained analysis
between two paired groups was undertaken using the two-
tailed Mann-Whitney U test (Minitab system, using the
University of Birmingham IBM 3090 mainframe computer).
Significance was taken as P<0.05, except in the case of fatty
acid analysis when significance was taken as P<0.01 due to
the large number of computations.
Results
The weights of the animals during the course of the experi-
ment are given in Table II and tumour sizes in Table III. The
initial reduction in numbers at week 1 was due to non-
tumour take. Subsequent reduction in numbers was due to
poor health from tumour size. Four of eight animals with
HT-29 inoculations receiving the coconut diet were sacrificed
at 24 days (because of large tumours) but are included as if
at 28 days. There were no significant differences between the
groups in terms of change of weight. Tumour volumes and
weights were significantly smaller in the Maxepa-fed animals
compared to control-diet and coconut-fed animals. There
were no significant differences between the tumour sizes of
the last two groups.
The histology of the COLO-320 tumours revealed ana-
plastic high grade carcinomas with extensive necrosis. The
mean (± s.d.) mitotic indices were: coconut group 7.1 ± 3.08
mitoses HPF-', Maxepa group 6.30 ± 3.37 and for the con-
trol group 6.42 ± 4.07. The histology of the HT-29 tumours
revealed poorly differentiated adenocarcinomas with foci of
necrosis. The mitotic indices were: coconut group 6.6 ± 4.4
mitoses HPF-', Maxepa group 5.7 ± 3.6 and for the control
group 4.8 ± 3.0. Analysis of co-variance revealed no statis-
tical difference. Histologically there was no distinction to be
made according to dietary group.
The fatty acid content of red blood cell membranes and
adipose tissue are shown in Tables IV and V respectively.
Important features to note are (1) incorporation of 18:2 (n-6)
in both types of tissue corresponds to dietary intakes of 18:2
(n-6) in the different groups; (2) in the Maxepa-fed animals
there is a greater degree of incorporation of n-3 fatty acids in
red cell membranes relative to adipose tissue.
The fatty acid content in tumour neutral lipid and phos-
pholipid fractions are shown in Tables VI and VII respec-
tively. In both tumour types from animals fed Maxepa, only
2:5 (n-3) and 22:6 (n-3) appeared in the neutral lipid fraction
whereas 22:5 (n-3) was present in the phospholipid fraction
as well. A marked reduction of 18:2 (n-6) was found in both
tumour types from animals fed Maxepa compared to
tumours from both the other dietary groups.
Discussion
This study has established for the first time that it is possible
to restrict the growth of two human colon cancer cell lines in
vivo using a diet high in n-3 lipids. Significant reduction in
tumour size occurred not only compared to an equivalent
saturated fat diet, but also compared to an isocaloric low fat
standard diet. Both the Maxepa and coconut diets were well
tolerated by the experimental animals given control inocula-
tions. The COLO-320 tumours were also well tolerated by
the animals for the duration of the experiment; however, the
Table II Animal weights (wt) during the course of the experiment according to different cell line
inoculation (or controls) and according to different dietary regimens
Animal weights (g, mean±s.d.)
Week I Week 2 Week 3 Week 4
Cell line Diet Number (n) Wt (n) Wt (n) Wt (n) Wt
COLO-320 Standard 12 (7) 21.1±2.9 (7) 21.7±3.0 (7) 23.6±2.7 (6) 25.1±3.2
COLO-320 Coconut 12 (10) 23.5±2.6 (10) 25.5±2.1 (10) 25.1±2.1 (10) 26.1 1.9
COLO-320 Mexapa 13 (13) 23.1±3.2 (13) 24.9±3.5 (13) 25.2±3.1 (13) 25.2±3.2
HT-29 Standard 13 (13) 24.5±1.5 (13) 23.5±1.8 (13) 23.8±2.0 (11) 24.1±2.3
HT-29 Coconut 12 (10) 23.9±2.1 (10) 24.5±2.5 (9) 24.8±2.7 (8) 25.1±2.9
HT-29 Maxepa 13 (12) 22.7±2.7 (12) 21.1±2.4 (9) 22.2±2.7 (9) 25.8±1.9
PBS* Standard 5 (5) 22.6±3.1 (5) 23.2± 1.9 (5) 23.9±2.3 (5) 24.5±3.0
PBS Coconut 5 (5) 23.1±3.6 (5) 21.6± 3.7 (5) 24.5±3.2 (5) 24.5±2.9
PBS Maxepa 5 (5) 24.9±2.4 (5) 25.1± 2.4 (5) 23.4±2.4 (5) 24.0±1.4
'Phosphate buffered saline.
Table III Tumour size according to the various cell line inoculations and type of diet
Tumour volume (ml, mean±s.d.)
Number (n) Week 1 (n) Week 2 (n) Week 3 (n) Week 4
12 (7) 0.025±0 (7) 0.074±0.049 (7) 0.247±0.161 (6) 0.597±0.167
12 (10) 0.025±0 (10) 0.064±0.029 (10) 0.143±0.050b (10) 0.605±0.384a
13 (13) 0.025±0 (13) 0.051±0.013 (13) 0.089±0.042d (13) 0.265±0.163d
Twmour weight
(g, mean±s.d.)
(n) Week 4
(6) 0.609±0.336
(10) 0.599±0.34lb
(13) 0.278±0.160'
HT-29 Standard 13 (13) 0.025±0 (13) 0.068±0.034 (13) 0.257±0.178 (11) 0.555±0.418 (11) 0.560±0.321
HT-29 Coconut 12 (10) 0.025±0 (10) 0.088±0.089 (8) 0.329±0.235 (8) 0.484±0.229a (8) 0.490±0.251'
HT-29 Maxepa 13 (10) 0.025±0 (10) 0.051±0.035 (9) 0.182±0.159 (9) 0.268±0.161' (9) 0.265±0.163c
Coconut vs Maxepa: 'P<0.05; bp<0.o1. Maxepa vs standard: CP<0.05; dp<0.o 1. Coconut vs standard: all not significant.
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Table IV Fatty acid composition of red blood cell membranes according to the various cell line
inoculations and type ofdiet
COLO-320 HT-29
Standard Coconut Maxepa Standard Coconut Maxepa
Fatty acid n=7 n=10 n=5 n=5 n=5 n=5
14:0 <0.1 0.8±1.0 0.7±0.7 2.1±1.4 0.4±0.5 0.1±0.1
16:0 30.3±0.8 28.8±4.0 25.5±5.8 25.4±1.9 25.8+3.8 20.1+2.5
16:1 (n-7) <0.1 <0.1 1.7+1.2a,b 3.2± 1.1 0.2±0.1 1.0±0.2a
18:0 12.3±0.7 11.8±2.2 10.4±1.9 13.2±2.0 14.3±2.4 10.6±1.7
18:1 (n-9) 10.7±0.3 13.8±2.3 8.9+11a,b 11.1± 1.0 16.9±2.7 8.7±1.la
18:2 (n-6) 9.5±0.5 6.9±1.8 2.7+1ja,b 10.2±0.4 9.0±1.1 2.3±0.4a,b
18:3 (n-6) <0.1 0.7±1.3 0.2±0.3 <0.1 <0.1 <0.1
20:3 <0.1 0.8± 1.3 <0.1 <0.1 <0.1 <0.1
20:4 (n-6) 26.0±0.9 21.3±6.6 8.0+2.2a,b 20.7±2.4 19.5± 1.6 8.5+±1.5a,b
20:5 (n-3) <0.1 <0.1 11.8+1.2a,b <0.1 <0.1 12.8+07a,b
22:4 (n-6) 7.0±0.3 13.0±4.0 1.0 1.0a,b 5.2± 1.5 8.8±2.0 <0.1a,b
22:5 (n-3) <0.1 <0.1 3.7+ 1.0a,b <0.1 <0.1 3.7+0.9ab
22:6 (n-3) <0.1 <0.1 23.4+3.2a,b <0.1 <0.1 21.4+2.5a,b
Values are % mean±s.d. Maxepa vs coconut: aP<0.01. Maxepa vs standard: bp<0.01.
Table V Fattyacidcompositionofadiposetissueaccording tothevariouscelllineinoculationsandtypeof
diet
COLO-320 HT-29
Standard Coconut Maxepa Standard Coconut Maxepa
Fatty acid n=5 n=5 n=5 n=5 n=5 n=5
10:0 <0.1 0.8± 1.7 <0.1 <0.1 <0.1 <0.1
12:0 <0.1 8.6±2.2 <O.la <0.1 7.2± 1.3 <0.la
14:0 2.2±4.4 7.7±2.5 3.0±1.8a 4.0±2.0 2.0±0.5 2.1±0.8
16:0 25.0±5.4 19.4±2.6 31.2±5.Oa 19.5±2.0 18.1 ±2.0 26.8±3.3a
16:1 (n-7) 0.9±0.9 6.6±2.5 7.5±2.4b 1.3±0.9 4.9±0.9 7.0± 1.7b
18:0 22.4± 5.6 6.3±4.0 4.0±0.8b 13.4±2.9 10.7±2.4 4.5±1.3a,b
18:1 (n-9) 24.4±4.4 28.3± 7.1 27.9± 3.5 31.3± 3.1 28.1±2.3 20.6+3.4a,b
18:2 (n-6) 11.3±2.5 7.7±2.7 3.20.8a,b 10.1±1.7 9.9±1.2 4.9+.1 ab
20:4 (n-6) 13.4±3.7 6.2±5.9 1.5±0.6b 15.2±2.7 13.3±2.3 3.20.8a,b
20:5 (n-3) <0.1 <0.1 5.8+2.4ab <0.1 <0.1 10.1±+08a,b
22:5 (n-3) <0.1 <0.1 1.2+0.7a.b <0.1 <0.1 1.4+0.4a,b
22:6 (n-3) <0.1 <0.1 9.2+2.1a,b <0.1 <0.1 10.2+0.3ab
Values are % mean±s.d. Maxepa vs coconut: 'P<0.01. Maxepa vs standard: bP<0.01.
Table VI Fatty acid composition of the neutral lipid fraction from tumours in the different dietary
groups
COLO-320 HT-29
Standard Coconut Maxepa Standard Coconut Maxepa
Fatty acid n=5 n=6 n=6 n=5 n=5 n=5
12:0 <0.1 0.54±0.43 <0.1 <0.1 0.25±0.11 <0.1
14:0 0.04±0.05 0.23±0.23 <0.la 0.08±0.3 0.30±0.17 0.06±0.07
16:0 1.72±0.17 1.75±0.59 1.96±0.24 0.97±0.14 1.23±0.13 1.15±0.07
16:1 (n-7) 0.35±0.25 0.76±0.44 0.50±0.22 0.22±0.15 0.45±0.11 0.35±0.09
18:0 0.41±0.16 0.62±0.38 0.63±0.18 0.21±0.12 0.40±0.05 0.35±0.17
18:1 (n-9) 2.73±0.17 2.20±0.97 2.29±0.60 2.01±0.12 1.79±0.16 1.26±0.26
18:2 (n-6) 1.43±0.35 0.60±0.23 0.38± 0.20b 1.35±0.27 0.78±0.21 0.25±0.1 b
20:4 (n-6) 0.29±0.23 0.20±0.07 0.15±0.06 1.15±0.19 0.61±0.25 0.15±0.07a,b
20:5 (n-3) <0.1 <0.1 0.41+0.10ab <0.1 <0.1 0.50+0.10ab
22:6 (n-3) <0.1 <0.1 0.94±0.22a.b <0.1 <0.1 0.92+0.24a,b
Values are nmol fattyacid permg tumourprotein; mean±s.d. Maxepa vscoconut: ap<0.01. Maxepa vs
standard: bP<0.01.
growth rate of HT-29 tumours was quite rapid between week
2 and week 4 necessitating early death in 11 out of 35
animals. In our experimental design we chose only to include
animals in whom the inoculated cells became firmly estab-
lished at I week. Although this occurred in only seven of 12
animals in the group inoculated with COLO-320 cells receiv-
ing a control diet, we consider this to have been a chance
event. In order to improve the possibility of establishing
growth, we selected a relatively high number of cells to be
inoculated (I x 107). An alternative might be to combine a
lower cell number inoculation containing stromal cells (Prit-
chard et al., 1989); in this situation, however, it may be
difficult to differentiate stromal cell growth from tumour cell
growth. Even so, failure to establish growth still occurs and
emphasises the value of using weekly assessment of tumour
growth as undertaken in the present study.
Although the three different animal diets were well match-
ed, there were small but potentially important differences
between them. Both the high fat diets contained more vita-
min E than the standard diet. The requirement for vitamin E
(and other anti-oxidants) is dependent upon the dietary level
of polyunsaturated fatty acids. A ratio of at least 0.6 (mg of
vitamin E per g of polyunsaturated fatty acids) is required to
prevent the development of vitamin E deficiency (Harris &
Embree, 1963). On the other hand the presence of vitamin E
which is surplus to this requirement may influence tumour
growth. In in vitro systems, vitamin E inhibits breast tumour
cell cytotoxicity induced by polyunsaturated fatty acids746 M. SAKAGUCHI et al.
Table VII Fatty acid composition of the phospholipid fraction from tumours in the different dietary
groups
COLO-320 HT-29
Standard Coconut Maxepa Standard Coconut Maxepa
Fatty acid n=5 n=6 n=6 n=5 n=5 n=5
14:0 <0.01 0.24±0.13 0.2±0.1 <0.01 0.08±0.08 0.02±0.01
16:0 0.69±0.37 0.64±0.17 0.6±0.2 0.57±0.19 0.48±0.03 0.38±0.07
16:1 (n-7) <0.01 0.33±0.23 0.16±0.04 0.20±0.05 0.21±0.07 0.14±0.03
18:0 0.77± 0.29 0.81 ±0.33 0.65±0.07 0.98±0.09 0.89± 0.22 0.50± 0.24
18:1 (n-9) 1.98±0.50 1.05±0.64 0.86±0.20 1.38±0.16 1.17±0.27 1.10±0.35
18:2 (n-6) 0.92±0.23 0.50±0.10 0.180±04a,b 0.56±0.13 0.74±0.09 0.18+0.11a,b
20:4 (n-6) 0.30±0.04 0.57±0.14 0.29±0.12a 0.22±0.03 0.91±0.16 0.34±0.20a
20:5 (n-3) <0.01 <0.01 0.420.03a,b <0.01 <0.01 0.74±0.29a,b
22:5 (n-3) <0.01 <0.01 0.37+0.18a,b <0.01 <0.01 0.01 +0.Ola,b
22:6 (n-3) <0.01 <0.01 0.51+0.13a,b <0.01 <0.01 0.77+0.25a,b
Values are nmol fattyacid permg tumourprotein; mean±s.d. Maxepa vscoconut: ap<0.o1. Maxepa vs
standard: bp<O.Ol.
(Begin, 1987), while in vitro it inhibits chemically induced
breast carcinogenesis (Horvarth & Ip, 1983). Nevertheless,
using experimental systems involving breast cancer as a
benchmark the levels ofvitamin E used in all three diets were
unlikely to influence tumour growth (Begin, 1987; Horvarth
& Ip, 1983).
Another difference in the diets was the presence of a small
amount of cholesterol in the Maxepa diet. A dietary level of
1% cholesterol may promote chemically-induced colorectal
tumours (Broitman et al., 1977; Hiramatsu et al., 1983) or
even less when compared to an elemental diet (Cruse et al.,
1984). In the present study, however, the Maxepa diet
reduced tumour growth compared to the other two diets.
Ingested fatty acids were utilised for energy production by
beta-oxidation, storage in adipose tissue and incorporation
into lipid membranes. As anticipated, marked qualitative
differences were found in the distribution of fatty acids in
adipose tissue and red cell membranes, which were related to
the three different types of dietary intake. These effects were
less marked in quantitative terms in the adipose tissue which
tends to store fatty acids as derived from the diet. Subse-
quent utilisation will be dependent upon the requirements for
(1) energy and (2) incorporation into membranes which will
necessitate further metabolism in order to maintain mem-
brane fluidity by balancing the proportion of saturated to
unsaturated fatty acids (Popp-Snijders et al., 1986). The latter
will be dependent on the main substrate polyene fatty acids
derived from the diet, i.e. 18:2, n-6 or 18:3, n-3 and the
preference of delta-6-desaturase for these substrates: 18:3,
n-3 > 18:2, n-6, > 18:1, n-9, > 16:1, n-7 (Jeffcoat & James,
1984). As illustrated in Tables IV and V, such processes are
taking place in our experimental model with regards to both
cancer cell lines.
Experimental work by Kitada et al. (1981) has indicated
that lipid mobilisation in tumour-bearing mice is largely
utilised for membrane synthesis by tumours rather than
energy utilisation by beta-oxidation which occurs in normal
mice. The major effects shown in our experimental model are
again consistent with this, although the extent to which the
fatty acids are derived directly from the diet or via temporary
storage in the labile fatty acid pool of adipose tissue is not
quantifiable (Tables VI and VII). The most marked differ-
ences were observed in the phospholipid fraction which is the
fraction most metabolically labile. In the Maxepa-fed animals
both tumour types incorporated large amounts of the main
n-3 fatty acids at the expense of 18:2, n-6. Whether this is
simply a reflection of substrate availability or a preference for
re-esterification of n-3 fatty acids is not certain. In general,
the profile of tumour FAMES was more similar to the
changes observed in adipose tissue compared to that occurr-
ing in the red cell membranes. What is certain is that altera-
tion of dietary fatty acid intake will result in dramatic
tumour lipid alterations. These effects may be amplified by
tumour-derived lipolytic factors (Kitada et al., 1981; Beck &
Tisdale, 1987) which will tend to release fatty acids from the
labile fatty acid pools of adipose tissue which have been
recently deposited there from the diet.
Reduction in experimental colon-cancer has recently been
demonstrated in rodent models receiving azoxymethane using
either fish-oil supplements (Reddy & Maruyam, 1986; Reddy
& Sugie, 1988) or eicosapentaenoic acid (20:5, n-3) as the
ethyl ester (Minoura et al., 1988). Changes in tumour lipid
composition were observed similar to those reported in the
current model (Reddy & Sugie, 1988; Minoura et al., 1988).
A previous transplanted tumour model did not demonstrate
any tumour growth reduction despite apparently similar
alterations in tumour lipids in animals fed fish oil (Fady et
al., 1988). There may be several reasons for this: (1) an
unusual model has been used, i.e. the rat DHD PROb colon
cell line transplated into BDIX synergenic rats; (2) the n-3
diet contained only 9% fish oil which contained only 18%
n-3 fatty acids; (3) only 6.8% of the fish oil diet contained
20:5, n-3; (4) tumour lipid incorporation consisted of 7.8%
20:5, n-3 and 17.3% 22:6, n-3. This compares with a total of
30.3% n-3 fatty acids in phospholipid fraction of COLO-320
tumours fed Maxepa and 36.4% similarly in the HT-29
tumours; moreover, the 20:5, n-3 content was 9.9% and
17.8% respectively. This would suggest that in the present
study almost complete saturation by n-3 fatty acids of the
sn-2 position of tumour phospholipids had occurred. It
would appear that both a high n-3 dietary content is required
(20%), and that a high proportion of this shouid be 20:5, n-3
for effective tumour growth suppression.
Mitotic index analysis of both tumours surprisingly did not
reveal any significant changes by diet. The mitotic activity
was very high in both tumour types corresponding to the
generally high growth rates. This would imply that the effect
of n-3 fatty acids is to contribute to tumour cell destruction
rather than to impede cellular division. The mechanism of
action of fish oil remains to be elucidated. Possibilities in-
clude inhibition of cyclo-oxygenase systems (Culp et al.,
1979; Corey et al., 1983) and increased lipid peroxidation
(Begin & Das, 1986; Begin & Ells, 1987; Begin et al., 1986,
1988; Cheeseman et al., 1986). Moreover, in investigating
these mechanisms it will be necessary to determine whether
the effects are due to a specific n-3 fatty acid and conversely
whether similar effects are obtained with n-6 fatty acids.
We are indebted to the Cancer Research Campaign, Dudley Road
Hospital and Duncan Flockhart (Glaxo) for financial support. Mr
A. Davis, Mr C. Imray, Mr J.P. Neoptolemos and Dr P. Baker are
supported by the Cancer Research Campaign. We are grateful to
Mrs Dilys Thomas and the Medical Illustration Department, Dudley
Road Hospital for preparation of figures and the manuscript.N-3 LIPIDS IN COLONIC CANCER CELL LINES 747
References
ARMSTRONG, B. & DOLL, R. (1975). Environmental factors and
cancer incidence and mortality in different countries, with special
reference to dietary practices. Int. J. Cancer, 15, 617.
BECK, S.A. & TISDALE, M.J. (1987). Production of lipolytic and
proteolytic fators by a murine tumor-producing cachexia in the
host. Cancer Res, 47, 5919.
BEGIN, M.E. (1987). Effects of polyunsaturated fatty acids and their
oxidation products on cell survival. Chem. Phys. Lipids, 45, 269.
BEGIN, M.E. & DAS, U.N. (1986). Selected fatty acids as possible
immediates for selective cytotoxic activity of anticancer agents
involving oxygen radicals. Anticancer Res., 6, 291.
BEGIN, M.E. & ELLS, G. (1987). Effects of C18 fatty acids on breast
carcinoma cells in culture. Anticancer Res., 7, 215.
BEGIN, M.E., ELLS, G., DAS, U.N. & HORROBIN, D.F.D. (1986).
Differential killing of human carcinoma cells supplemented with
n-3 and n-6 polyunsaturated fatty acids. J. Natl Cancer Inst., 77,
1053.
BEGIN, M.E., ELLS, G. & HORROBIN, D.F.D. (1988). Polyunsaturated
fatty acid-induced cytotoxicity against tumor cells and its rela-
tionship to lipid peroxidation. J. Natl Cancer Inst., 80, 188.
BINGHAM, S.A. (1987). The dietary assessment of individuals:
methods, accuracy, new techniques and recommendations. Nutr.
Abst. Rev., 57, 705.
BLIGH, E.C. & DYER, W.J. (1959). A rapid method of total lipid
extraction and purification. Can. J. Biochem. Physiol., 37, 111.
BRASITUS, T.A., DAVIDSON, N.D. & SCHACTER, D. (1985). Varia-
tions in dietary triacylglycerol saturation alter the lipid composi-
tion and fluidity of rat intestinal plasma membranes. Biochim.
Biophys. Acta., 812, 460.
BROITMAN, S.A., VITALE, J.J., VAVROUSER-JAKUBA, E. & GOTT-
LIEB, L.S. (1977). Polyunsaturated fat, cholesterol and large
bowel tumorigenesis. Cancer, 40, 2455.
BULL, A.W., SOULLIER, B.K., WILSON, P.S., HAYDEN, M.T. &
NIGRO, N.D. (1979). Promotion of azoxymethane-induced intes-
tinal cancer by high-fat diet in rats. Cancer Res., 39, 4956.
CHEESEMAN, K., COLLINS, M., PROUDFOOT, K. & 4 others (1986).
Studies on lipid peroxidate in normal and tumour tissues.
Biochem. J., 235, 507.
COREY, E.J., SHIH, C. & LASHMAN, J.R. (1983). Docosahexaenic acid
is a strong inhibitor of prostaglandin but not leukotriene biosyn-
thesis. Proc. Natl Acad. Sci. USA, 80, 3581.
CRUSE, J.P., LEWIN, M.R. & CLARK, C.G. (1984). An investigation
into the mechanism of co-carcinogenesis of dietary cholesterol
during the induction of colon cancer in rats by 1,2-dimethyl-
hydrazine. Clin. Oncol., 10, 213.
CULP, B.R., TITUS, B.G. & LANDS, W.E.M. (1979). Inhibition of
prostaglandin biosynthesis by eicosopentaenoic acid. Prostagland-
ins Med., 3, 269.
DAYTON, S., HASHIMOTO, S. & WOLLMAN, J. (1977). Effect of
high-oleic and high linoleic safflower oils on mammary tumors
induced by rats by 7,12-dimethylbenz(a)anthracene. J. Nutr., 107,
1353.
EUHUS, D.M., HUDD, C., LAREGINA, M.C. & JOHNSON, F.E. (1986).
Tumour measurement in the nude mouse. J. Surg. Oncol., 31,
229.
FADY, C., REISSER, D., LAGADEC, P., PELLETIER OLSON, N.D. &
JEANIN, J.F. (1988). In vivo and in vitro effects of fish-containing
diets on colon tumour cells in rats. Anticancer Res., 8, 225.
FIENNES, A.G.T.W. (1988). Growth rate of human tumour xenografts
measured in nude mice by in vivo cast modelling. Br. J. Surg., 75,
23.
FRIEDMAN, E., ISAKSSON, P., RAFTER, J., MARIAN, B., WINAWER,
S. & NEWMARK, H. (1989). Fecal diglycerides as selective endo-
genous mitogens for premalignant and malignant human colonic
epithelial cells. Cancer Res., 49, 544.
GALLOWAY, D.J., JARRETT, F., BOYLE, P. & 4 others (1987). Mor-
phological and cell kinetic effects of dietary manipulation during
colorectal carcinogenesis. Gut, 28, 754.
HARRIS, P.L. & EMBREE, N.D. (1963). Quantitative consideration of
the effect of polyunsaturated fatty acid content of the diet upon
the requirements for vitamin E. Am. J. Clin. Nutr., 13, 385.
HIRAMATSU, Y., TAKADA, H., YAMAMURA, M., HIOKI, K., SAITO,
K. & YAMAMOTO, M. (1983). Effect of dietary cholesterol on
azoxymethane-induced colon carcinogenesis in rats. Carcino-
genesis, 4, 553.
HORVARTH, P.M. & IP, C. (1983). Synergistic effect of vitamin E and
selenium in the chemoprevention of mammary carcinogenesis in
rats. Cancer Res., 43, 5535.
JEFFCOAT, R. & JAMES, A.T. (1984). The regulation of desaturation
and elongation of fatty acids in mammals. In Fatty Acid Meta-
bolism and Its Regulation, Numar, S. (ed.) p. 85. Elsevier Science
Publishers: Amsterdam.
KANAN, R., LYON, I. & BAKER, N. (1980). Dietary control of lipo-
genesis in vivo in host tissues and tumours of mice bearing
Enrlich ascites carcinoma. Cancer Res., 40, 4606.
KITADA, S., HOYS, E.F. & MEAD, J.F. (1981). Characterization of a
lipid mobilizing factor from tumours. Prog. Lipid Res., 20, 823.
LEGASPI, A., JEEVANANDANM, M., STARNES, H. & BRENNAN, M.F.
(1987). Whole lipid and energy metabolism in the cancer patients.
Metabolism, 36, 958.
LOCKNISKAR, M., NAUSS, K.M., KAUFFMAN, P. & NEWBEANE,
P.M. (1985). Interaction of dietary fat and route of carcinogen
administration of 1,2-di-methylhydrazine-induced colon tumori-
genesis in rats. Carcinogenesis, 6, 349.
LOWRY, D.H., ROSEBROUGH, N.J., FARR, A.L. & RANDALL, R.J.
(1951). Protein measurement with the Folin phenol reagent. J.
Biol. Chem., 193, 265.
MCGEE, R. & SPECTOR, A.A. (1975). Fatty acid biosynthesis in Ehr-
lich cells. The mechanism of short term control by exogenous free
fatty acids. J. Biol. Chem., 250, 5419.
MINOURA, T., TAKATA, T., SAKAGUCHI, M. & 4 others (1988).
Effect of dietary eicosapentaenoic acid on azoxymethan-induced
colon carcinogenesis in rats. Cancer Res., 48, 4790.
NEOPTOLEMOS, J.P. & THOMAS, B.S. (1990). Red cell membrane
fatty acid profiles in colorectal cancer using tube capillary gas
chromatography. Ann. Clin. Biochem., 29, 38.
NICHOLSON, M.L., NEOPTOLEMOS, J.P., CLAYTON, H.A. &
HEAGERTY, A.M. (1988). Diet and colorectal cancer. Int. Clin.
Nutr. Rev., 8, 180.
NICHOLSON, M.L., NEOPTOLEMOS, J.P., CLAYTON, H.A., TALBOT,
I.C. & BELL, P.R.F. (1990a). Increased arachidonic acid in cell
membranes of experimental colorectal tumours. Gut (in the
press).
NICHOLSON, M.L., NEOPTOLEMOS, J.P., CLAYTON, H.A., TALBOT,
I.C. & BELL, P.R.F. (1990b). Fatty acids in experimental colorectal
carcinogenesis. (Abstract). Br. J. Surg. (in the press).
NIGRO, N.D., SINGH, D.V., CAMPBELL, R.L. &PAK, M.S. (1975). Effect
ofdietary beeffat on intestinal tumour formation by azoxymethane
in rats. J. Natl Cancer Inst., 54, 439.
OOKTENS, M., MONTISANO, D., LYON, I. & BAKER, N. (1986). Inhibi-
tion of fatty acid incorporation into adipose tissue triglycerides in
Ehrlich ascites tumor-bearing mice. Cancer Res., 46, 633.
POPP-SNIJDERS, C., SCHOUTEN, J.A., VAN BLITTERWIJK, W.J. & VAN
DERVEEN, E.A. (1986). Changes in membrane lipid composition of
human erythrocytes after dietary supplementation of(n-3) polyun-
saturated fatty acids. Maintenance ofmembrane fluidity. Biochim.
Biophys. Acta., 85, 31.
PRITCHARD, G.A.,JONES, D.L.&MANSEL, R.E. (1989). Lipidsinbreast
carcinogenesis. Br. J. Surg., 76, 1069.
REDDY, B.S. & MARUYAMA, H. (1986). Effect of dietary fish oil on
azoxymethane-induced colon carcinogenesis in male F344 rats.
Cancer Res., 46, 3367.
REDDY,B.S.&SUGIE,S.(1988). Effectofdifferent levels ofomega-3 and
omega-6 fatty acids on azoxymethane-induced colon carcinogenesis
in F344 rats. Cancer Res., 48, 6642.
REDDY, B.S., TANAKA, T. & SIMI, B. (1985). Effect ofdifferent levels of
dietary trans fat or corn oil on azoxymethane-induced colon
carcinogenesis in F.344 rats. J. Natl Cancer Inst., 75, 791.
REDDY, B.S., WATANABE, K. & WEISBURGER, J.H. (1977). Effect of
high-fat diet on colon carcinogenesis in F344 rats treated with
1,2-dimethylhydrazine, methylazoxymethanol acetate or methyl-
nitrosourea. Cancer Res., 37, 4156.
SAKAGUCHI, M., HIRAMATSU, Y., TAKADA, H. & 4 others (1984).
Effect ofdietary unsaturated and saturated fats on azoxymethane-
induced colon carcinogenesis in rats. Cancer Res., 44, 1472.
SCHLAGER, S.E. & OHANIAN, S.H. (1980). Modulation oftumour cell
susceptibility to humoral immune killing through chemical and
physical manipulation of cellular lipid and fatty acid compositon.
J. Immunol., 125, 1196.
SMEDLEY-MACHLEAN, I. & NUNN, L.C.A. (1941). Fat-deficiency
disease of rats. The relation of the essential unsaturated acids to
tumour formation ofthe albino rat on normal diet. Biochem. J., 35,
983.
WALD, N.S., BOREHAM, J. & BAILEY, A. (1986). Serum retinol and the
subsequent risk of cancer. Br. J. Cancer, 54, 957.
WICKREMASINGHE, R.G. (1988). The role of prostaglandins in the
regulation of cell proliferation. Prostaglandins Leukotrienes
Essent. Fatty Acids, 31, 171.
WILSON, J.D. & LINDSEY, C.A. (1965). Studies on the influence of
dietary cholesterol on cholesterol metabolites in the iso-topic steady
state in man. J. Clin. Invest., 44, 1805.